BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 16199319)

  • 1. Changes in tumor cell response due to prolonged dose delivery times in fractionated radiation therapy.
    Paganetti H
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):892-900. PubMed ID: 16199319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT.
    Shibamoto Y; Ito M; Sugie C; Ogino H; Hara M
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1484-90. PubMed ID: 15275736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the temporal pattern of radiation: an IMRT based study.
    Altman MB; Chmura SJ; Deasy JO; Roeske JC
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):898-905. PubMed ID: 17011463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor cell survival dependence on helical tomotherapy, continuous arc and segmented dose delivery.
    Yang W; Wang L; Larner J; Read P; Benedict S; Sheng K
    Phys Med Biol; 2009 Nov; 54(21):6635-43. PubMed ID: 19826199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of temporal optimization effects for a single fraction of radiation in vitro.
    Altman MB; Stinauer MA; Javier D; Smith BD; Herman LC; Pytynia ML; Aydogan B; Pelizzari CA; Chmura SJ; Roeske JC
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1240-6. PubMed ID: 19857787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro determination of radiation sensitivity parameters for DU-145 prostate cancer cells.
    Wang JZ; Rhee JG; Shi P; Stewart RD; Allen Li X
    Int J Radiat Biol; 2008 Jun; 84(6):515-22. PubMed ID: 18470750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line.
    Hermens AF; Bentvelzen PA
    Cancer Res; 1992 Jun; 52(11):3073-82. PubMed ID: 1591720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
    Wilkins RC; Ng CE; Raaphorst GP
    Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-rate effects in mammalian cells. IV. Repairable and nonrepairable damage in noncycling C3H 10T 1/2 cells.
    Wells RL; Bedford JS
    Radiat Res; 1983 Apr; 94(1):105-34. PubMed ID: 6856762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy.
    Sterzing F; Münter MW; Schäfer M; Haering P; Rhein B; Thilmann C; Debus J
    Strahlenther Onkol; 2005 Jan; 181(1):42-8. PubMed ID: 15660192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable cell survival between high dose rate flattening filter free and conventional dose rate irradiation.
    Verbakel WF; van den Berg J; Slotman BJ; Sminia P
    Acta Oncol; 2013 Apr; 52(3):652-7. PubMed ID: 23126524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitivity of human cell lines to small doses. Are there some clinical implications?
    Malaise EP; Lambin P; Joiner MC
    Radiat Res; 1994 Apr; 138(1 Suppl):S25-7. PubMed ID: 8146319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the temporal effects of respiratory-gated and intensity-modulated radiotherapy treatment delivery on in vitro survival: an experimental and theoretical study.
    Keall PJ; Chang M; Benedict S; Thames H; Vedam SS; Lin PS
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1547-52. PubMed ID: 18495369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of stochastic fluctuation in radiation dose-rate on cell survival following fractionated radiation therapy.
    Paul S; Roy PK
    Phys Med Biol; 2012 Mar; 57(6):1561-73. PubMed ID: 22391148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
    Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
    Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhenius relationships from the molecule and cell to the clinic.
    Dewey WC
    Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines.
    Fitzpatrick CL; Farese JP; Milner RJ; Salute ME; Rajon DA; Morris CG; Bova FJ; Lurie DM; Siemann DW
    Am J Vet Res; 2008 Sep; 69(9):1197-202. PubMed ID: 18764694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor.
    Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of biological effect in prolonged fraction delivery.
    Fowler JF; Welsh JS; Howard SP
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):242-9. PubMed ID: 15093921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.